Editorial: Checkpoint Inhibitor-Induced Liver Injury-Time to Abandon CTCAE? Authors' Reply

被引：0
|
作者：
Hountondji, Lina [1 ]
Meunier, Lucy [1 ,2 ,3 ]
机构：
[1] Montpellier Univ Hosp, St Eloi Hosp, Hepatol & Liver Transplantat Dept, Hepatol & Liver Transplantat Unit, Montpellier, France
[2] REFHEPS, Montpellier, France
[3] Montpellier Univ Hosp, St Eloi Hosp, Inst Regenerat Med & Biotherapy IRMB, Hepatol & Liver Transplantat Dept, Montpellier, France
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2024年 / 60卷 / 11-12期
关键词：
D O I：
10.1111/apt.18343
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1623 / 1624
页数：2
相关论文
共 50 条
  • [21] Computed tomography findings of hepatobiliary systems in patients with immune checkpoint inhibitor-induced liver injury
    Masuoka, Sota
    Hiyama, Takashi
    Kuno, Hirofumi
    Sasaki, Tomoaki
    Oda, Shioto
    Miyasaka, Yusuke
    Yamaguchi, Masayuki
    Kobayashi, Tatsushi
    ABDOMINAL RADIOLOGY, 2023, 48 (09) : 3012 - 3021
  • [22] EFFICACY OF UDCA AS FIRST-LINE TREATMENT FOR CHOLESTATIC CHECKPOINT INHIBITOR-INDUCED LIVER INJURY
    Meunier, Lucy
    Hountondji, Lina
    Faure, Stephanie
    Palassin, Pascale
    Pageaux, Georges-Philippe
    Maria, Alexandre
    HEPATOLOGY, 2024, 80 : S959 - S960
  • [23] Editorial: Safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis
    Hanauer, Stephen
    Wang, Yinghong
    Shatila, Malek
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (01) : 150 - 151
  • [24] Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAM
    Hountondji, Lina
    Faure, Stephanie
    Palassin, Pascale
    Viel, Philine Witkowski Durand
    Dupuy, Marie
    Larrey, Dominique
    Lamoureux, Anouck
    Coustal, Cyrille
    Pureur, Dimitri
    Lesage, Candice
    Assenat, Eric
    Riviere, Benjamin
    Faillie, Jean-Luc
    Quantin, Xavier
    Pageaux, Georges-Philippe
    Maria, Alexandre Thibault Jacques
    Meunier, Lucy
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (11-12) : 1561 - 1572
  • [25] Letter: immune checkpoint inhibitor-induced colitis-shouldn't we be checking more often? Authors' reply
    Wright, Andrew P.
    Piper, Marc S.
    Bishu, Shrinivas
    Stidham, Ryan W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (05) : 613 - 613
  • [26] CLINICAL CHARACTERISTICS AND OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR-INDUCED PANCERATIC INJURY
    Abu-Sbeih, Hamzah
    Tang, Tenglong
    Lu, Yang
    Thirumurthi, Selvi
    Rhim, Andrew D.
    Coronel, Emmanuel
    Wang, Yinghong
    GASTROENTEROLOGY, 2019, 156 (06) : S1044 - S1044
  • [27] Checkpoint inhibitor-induced liver injury (ChILI) in patients with advanced skin cancer: a single center experience
    Liguori, A.
    Archilei, S.
    Salvi, M.
    Marrone, G.
    Biolato, M.
    Miele, L.
    Pompili, M.
    Di Stefani, A.
    Peris, K.
    Gasbarrini, A.
    Grieco, A.
    DIGESTIVE AND LIVER DISEASE, 2025, 57
  • [28] Immune checkpoint inhibitor-induced gastrointestinal and hepatic injury: pathologists' perspective
    Karamchandani, Dipti M.
    Chetty, Runjan
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (08) : 665 - 671
  • [29] Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury
    Abu-Sbeih, Hamzah
    Tang, Tenglong
    Lu, Yang
    Thirumurthi, Selvi
    Altan, Mehmet
    Jazaeri, Amir A.
    Dadu, Ramona
    Coronel, Emmanuel
    Wang, Yinghong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [30] Varicella Hepatitis Mimicking Immune Checkpoint Inhibitor-induced Liver Toxicity
    Weiss, M. J.
    Zhang, X.
    Spengler, E. K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 761 - 761
12345